CGON - CG Oncology, Common stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CGON is currently covered by 3 analysts with an average price target of $73.26. This is a potential upside of $36.36 (98.54%) from yesterday's end of day stock price of $36.9.

CG Oncology, Common stock's activity chart (see below) currently has 0 price targets and 15 ratings on display. The stock rating distribution of CGON is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CGON is $75, Lowest price target is $66, average price target is $70.5.

Most recent stock forecast was given by JOSH SCHIMMER from CANTOR FITZGERALD on 08-Sep-2025. First documented stock forecast 20-Feb-2024.

Best performing analysts who are covering CGON - CG Oncology, Common stock:

Josh Schimmer Gregory Renza

Currently out of the existing stock ratings of CGON, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$41.66 (124.96%)

$75

11 days ago
(08-Sep-2025)

0/4 (0%)

$41.31 (122.62%)

Buy

$66

$32.66 (97.96%)

$66

9 months 13 days ago
(06-Dec-2024)

0/2 (0%)

$31.41 (90.81%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CGON (CG Oncology, Common stock) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CGON (CG Oncology, Common stock) with a proven track record?

JOSH SCHIMMER

Which analyst has the current lower performing score on CGON (CG Oncology, Common stock) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on CGON (CG Oncology, Common stock)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on CGON

Which analyst is the currently most bullish on CGON (CG Oncology, Common stock)?

Josh Schimmer with highest potential upside - $41.66

Which analyst is the currently most reserved on CGON (CG Oncology, Common stock)?

Gregory Renza with lowest potential downside - $32.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?